AstraZeneca PLC (NYSE:AZN)

53.76
Delayed Data
As of Jul 10
 -0.215 / -0.40%
Today’s Change
36.15
Today|||52-Week Range
57.44
+7.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line3.1B3.5B2.3B2.0B
 
 
 
 
 
Depreciation2.7B2.3B2.5B2.8B
 
 
 
 
 
Total Other Cash Flow-2.2B-2.5B-897.5M-1.3B
 
 
 
 
 
Funds From Operations3.5B3.4B3.8B3.4B
 
 
 
 
 
Funds From/For Other Operating Expenses48.9M-923.6M50.5M637.9M
 
 
 
 
 
Net Cash Flow - Operating Activities3.4B4.3B3.8B2.8B
 
 
 
 
 
 
InvestingIncrease In Investments-101.8M-435.9M-522.5M-288.5M
 
 
 
 
 
Decrease In Investments375.4M3.0M70.8M428.3M
 
 
 
 
 
Capital Expenditures-1.3B-1.4B-1.3B-1.0B
 
 
 
 
 
Fixed Asset Disposal46.9M81.8M83.9M12.0M
 
 
 
 
 
Net Assets From Acquisitions -3.0B-2.9B-1.9B-348.4M
 
 
 
 
 
Other Investing - Sources1.1B1.4B1.4B2.3B
 
 
 
 
 
Net Cash Flow Investing-4.4B-4.1B-2.5B768.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-1.5B-302.2M339.6M-97.8M
 
 
 
 
 
Long Term Borrowings5.9B2.5B0.000.00
 
 
 
Long Term Debt Reduction-41.9M-16.0M-14.2M0.00
 
 
 
 
Net Proceeds Stock Sale42.9M46.9M43.5M33.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends-3.5B-3.6B-3.6B-3.5B
 
 
 
 
 
Cash Dividends Paid - Total-3.5B-3.6B-3.6B-3.5B
 
 
 
 
 
Other Sources - Financing--18.0M0.000.00
 
 
Other Uses - Financing50.9M0.0020.2M66.9M
 
 
 
 
Net Cash Flow - Financing876.6M-1.3B-3.0B-2.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-75.9M20.9M-66.7M-37.9M
 
 
 
 
 
 
Net Change In Cash-36.9M-1.1B-1.7B1.5B